Connect with us

Business

AstraZeneca puts COVID-19 vaccine trial on hold – The Australian Financial Review

The drug maker said its “standard review process triggered a pause to vaccination to allow review of safety data”.

Published

on

AstraZeneca has put a hold on the late-stage trial of its highly-anticipated COVID-19 vaccine candidate after a suspected serious adverse reaction in a study participant, health news website Stat News reported.
It quoted an AstraZeneca spokesperson as saying in a statement that the “standard review process triggered a pause to vaccination to allow review of safety data.
Nine leading US and European vaccine developers pledged on Tuesday to uphold scientific safety and efficacy standards for the…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending